{"url":"https://lda.senate.gov/api/v1/filings/d8548318-ddfb-4f8a-b9fd-a91d2a2c1ffd/","filing_uuid":"d8548318-ddfb-4f8a-b9fd-a91d2a2c1ffd","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2023,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d8548318-ddfb-4f8a-b9fd-a91d2a2c1ffd/print/","filing_document_content_type":"text/html","income":"27000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Brynn Kiser","dt_posted":"2023-10-19T10:56:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20th F Street NW","registrant_address_2":"Floor 7","registrant_different_address":false,"registrant_city":"Washington, D.C","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400374717,"url":"https://lda.senate.gov/api/v1/registrants/400374717/","house_registrant_id":null,"name":"THE CONSILIO GROUP","description":"Government affairs","address_1":"20th F Street NW","address_2":"Floor 7","address_3":null,"address_4":null,"city":"Washington, D.C","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"OLIVER MEISSNER","contact_telephone":"+1 202-510-4897","dt_updated":"2026-07-29T15:53:28.689088-04:00"},"client":{"id":204972,"url":"https://lda.senate.gov/api/v1/clients/204972/","client_id":416,"name":"TRUTAG TECHNOLOGIES","general_description":"Product authentication","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-05-01"},"lobbying_activities":[{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"Pharmaceutical tracking capability","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45748,"prefix":null,"prefix_display":null,"first_name":"OLIVER","nickname":null,"middle_name":null,"last_name":"MEISSNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":80766,"prefix":null,"prefix_display":null,"first_name":"BRANDON","nickname":null,"middle_name":null,"last_name":"KIRBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140764,"prefix":"ms","prefix_display":"MS.","first_name":"MEAGAN","nickname":null,"middle_name":"ELIZABETH","last_name":"DALY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":133898,"prefix":null,"prefix_display":null,"first_name":"ETHAN","nickname":null,"middle_name":null,"last_name":"MAHLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Pharmaceutical tracking capability","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45748,"prefix":null,"prefix_display":null,"first_name":"OLIVER","nickname":null,"middle_name":null,"last_name":"MEISSNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":80766,"prefix":null,"prefix_display":null,"first_name":"BRANDON","nickname":null,"middle_name":null,"last_name":"KIRBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140764,"prefix":"ms","prefix_display":"MS.","first_name":"MEAGAN","nickname":null,"middle_name":"ELIZABETH","last_name":"DALY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":133898,"prefix":null,"prefix_display":null,"first_name":"ETHAN","nickname":null,"middle_name":null,"last_name":"MAHLER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Pharmaceutical tracking capability","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45748,"prefix":null,"prefix_display":null,"first_name":"OLIVER","nickname":null,"middle_name":null,"last_name":"MEISSNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":80766,"prefix":null,"prefix_display":null,"first_name":"BRANDON","nickname":null,"middle_name":null,"last_name":"KIRBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":13,"name":"Office of the Vice President of the United States"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}